Abstract
Individual sensitivity of blood neutrophils to IFN-α2a was studied in vitro in patients with renal cell cancer before and after the first course of reaferon therapy. Cell sensitivity changed after reaferon therapy in 85% patients. This necessitates evaluation of individual cell sensitivity not only before therapy, but also before the next course of therapy.
Similar content being viewed by others
References
D. N. Mayanskii and I. G. Ursov, Lectures in Clinical Pathology [in Russian], Novosibirsk (1997).
J. Kirkwood, Semin. Oncol., 29, No. 3, Suppl. 7, 18–26 (2002).
D. Nests, Interferons. Biological Activities and Clinical Efficacy, Berlin (1997), pp. 12–16.
G. Uze, G. Lutfalla, and K. E. Mgenesen, J. Interferon Cytokine Res., 15, No. 1, 3–26 (1995).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 144, No. 7, pp. 90–92, July, 2007
Rights and permissions
About this article
Cite this article
Shkapova, E.A., Kurtasova, L.M. & Savchenko, A.A. Cell sensitivity to reaferon in patients with renal cell cancer after reaferon therapy. Bull Exp Biol Med 144, 80–82 (2007). https://doi.org/10.1007/s10517-007-0260-2
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-007-0260-2